These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 14319572)

  • 1. [BEHAVIOR OF SERUM LIPIDS AND LIPOPROTEINS WITH ADMINISTRATION OF REGELAN (ETHYL-P-CHLOROPHENOXYISOBUTYRATE)].
    KNUECHEL F
    Med Welt; 1964 Nov; 47():2530-6. PubMed ID: 14319572
    [No Abstract]   [Full Text] [Related]  

  • 2. EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN NORMAL AND HYPERLIPIDEMIC SUBJECTS.
    HOWARD RP; ALAUPOVIC P; BRUSCO OJ; FURMAN RH
    J Atheroscler Res; 1963; 3():482-99. PubMed ID: 14100889
    [No Abstract]   [Full Text] [Related]  

  • 3. REDUCTION OF CHOLESTEROL AND LIPIDS IN MAN BY ETHYL P-CHLOROPHENOXYISOBUTYRATE.
    HELLMAN L; ZUMOFF B; KESSLER G; KARA E; RUBIN IL; ROSENFELD RS
    Ann Intern Med; 1963 Oct; 59():477-94. PubMed ID: 14067470
    [No Abstract]   [Full Text] [Related]  

  • 4. THE EFFECT OF SF 20-10-5 CONCENTRATION CHANGES INDUCED BY ETHYL CHLOROPHENOXYISOBUTYRATE ON HIGH-DENSITY LIPOPROTEIN LIPID COMPOSITION.
    STRISOWER EH; NICHOLS AV; LINDGREN FT; SMITH L
    J Lab Clin Med; 1965 May; 65():748-55. PubMed ID: 14281371
    [No Abstract]   [Full Text] [Related]  

  • 5. THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE.
    STRISOWER EH; STRISOWER B
    J Clin Endocrinol Metab; 1964 Feb; 24():139-44. PubMed ID: 14123837
    [No Abstract]   [Full Text] [Related]  

  • 6. REDUCTION OF SERUM CHOLESTEROL AND LIPIDS BY ETHYL CHLOROPHENOXYISOBUTYRATE.
    HELLMAN L; ZUMOFF B; KESSLER G; KARA E; RUBIN IL; ROSENFELD RS
    J Atheroscler Res; 1963; 3():454-66. PubMed ID: 14100886
    [No Abstract]   [Full Text] [Related]  

  • 7. HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
    BEST MM; DUNCAN CH
    J Lab Clin Med; 1964 Oct; 64():634-42. PubMed ID: 14233152
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of ethyl chlorophenoxyisobutyrate (CPIB) on blood lipids].
    Giannini SD; da Silva WN; Luthold WW; Coelho LT; Bitelli T
    Rev Bras Med; 1965 Nov; 22(11):702-7. PubMed ID: 5892979
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate.
    THORP JM; WARING WS
    Nature; 1962 Jun; 194():948-9. PubMed ID: 13921051
    [No Abstract]   [Full Text] [Related]  

  • 11. SERUM LIPOPROTEINS IN RATS WITH ETHIONINE-INDUCED FATTY LIVER.
    UGAZIO G; LOMBARDI B
    Lab Invest; 1965 Jun; 14():711-9. PubMed ID: 14319959
    [No Abstract]   [Full Text] [Related]  

  • 12. [EFFECT OF CARBON DISULFIDE ON BIOCHEMICAL CHANGES IN THE SERUM OF EXPOSED SUBJECTS IN RELATION TO ATHEROSCLEROSIS].
    PREROVSKA I; SRBOVA J
    Prac Lek; 1963 Jan; 15():25-30. PubMed ID: 14067056
    [No Abstract]   [Full Text] [Related]  

  • 13. THE RATE OF SERUM LIPOPROTEIN SYNTHESIS AND BREAKDOWN IN NORMAL RABBITS AND DURING EXPERIMENTAL ATHEROSCLEROSIS.
    LEVITOVA EN; KRITSMAN MG
    Cor Vasa; 1963; 5():282-7. PubMed ID: 14102112
    [No Abstract]   [Full Text] [Related]  

  • 14. [LIPID METABOLISM DISORDERS IN CHRONIC CARBON DISULFIDE POISONING].
    OLENIACZ W; PLAMIENIAK Z
    Pol Arch Med Wewn; 1963; 33():1179-82. PubMed ID: 14112485
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE BLOOD LIPID PICTURE IN CARBON DISULFIDE POISONING].
    MARTINO P; PERRELLI G; COSCIA GC
    Arch Sci Med (Torino); 1964 Mar; 117():124-30. PubMed ID: 14141595
    [No Abstract]   [Full Text] [Related]  

  • 16. [BLOOD LIPID PICTURE IN CARBON DISULFIDE POISONING. 1ST OBSERVATIONS].
    MARTINO P; COSCIA GC; PERRELLI G
    Folia Med (Napoli); 1963 Dec; 46():1110-4. PubMed ID: 14159387
    [No Abstract]   [Full Text] [Related]  

  • 17. [RELATIONS BETWEEN HYPOCHOLESTEREMIC DRUGS AND LIPID METABOLISM: ACTION OF BETA-BENZALBUTYRRAMIDE ON DYSLIPIDEMIA IN RATS FED A LOW-PROTEIN DIET].
    SANGUINETTI F; ZANNONI ML
    Minerva Med; 1963 Oct; 54():2925-9. PubMed ID: 14105485
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of ethyl alpha-p-chlorophenoxyisobutyrate (Clofibrate) on lipids, cholesterol and uric acid in diabetes mellitus].
    Orsetti A; Mirouze J
    Therapie; 1966; 21(3):685-91. PubMed ID: 5942133
    [No Abstract]   [Full Text] [Related]  

  • 19. [CLINICAL CONTRIBUTION TO THE STUDY OF A NEW SYNTHETIC ANTICHOLESTEREMIC AGENT: BETA-BENZALBUTYRRAMIDE].
    GIULIANI A; SAMMARTINO V
    Minerva Med; 1963 Oct; 54():2913-6. PubMed ID: 14105482
    [No Abstract]   [Full Text] [Related]  

  • 20. [STUDY ON THE HYPOCHOLESTEREMIC ACTION OF CETIMIPHEN (PHENEXOL) IN ARTERIOSCLEROTIC PATIENTS].
    NAZER AM
    Kardiologiia; 1964; 4():52-7. PubMed ID: 14152591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.